Incretin-Based Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-2051 | Report Format : | Status : Upcoming |

Abstract

Global Incretin-Based Drugs Market: Overview

When the blood glucose levels decrease a group of metabolic hormones is stimulated which is known as incretins. Incretin-based drugs include glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors which are the new group of drugs that are helpful in curing type 2 diabetes. These drugs have a positive effect on the body weight and have a low risk of hypoglycemia. The oral anti-diabetic drugs are unable to maintain the desired levels of glucose, especially during the conditions of postprandial, thus increasing the requirement for a better therapeutics such as the incretin-based drugs. The consumption of the incretin-based drugs increases the secretion of insulin and inhibits the release of glucagon.

Global Incretin-Based Drugs Market: Segmentation

The global market for the incretin-based drugs is fragmented into its drug type, formulation, and distribution channel. Depending on the drug type, the global market is segregated into dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 receptor (GLP-1) agonists. Depending on the formulation, the market is categorized into injectable drugs and oral drugs. Depending on the distribution channel, the market is divided into online pharmacies, hospital pharmacies, retail pharmacies, and others.

Global Incretin-Based Drugs Market: Growth Factors

The key factors that are driving the incretin-based drugs market are rising old age population, increased rate of obesity, sedentary lifestyle, increasing rate of people suffering from cardiovascular diseases and diabetes, and the increasing awareness among the people. The other factor that is driving the growth of the market is the rise in the number of patients that are undiagnosed and pre-diagnosed for the disease. There are certain factors that will restrain the growth of the market which include the absence of supportive reimbursement policies, lack of accessibility to the drugs, a high cost that is involved in the treatment and the increased safety concerns affect the market growth negatively.

Global Incretin-Based Drugs Market: Regional Analysis

According to the regional study, the global market for the incretin-based drugs is diversified into Eastern Europe, North America, Western Europe, Asia Pacific, the Middle East and Africa, and Latin America. There is an increased demand for the incretin-based drugs in the Asia Pacific region. While North America and Western European region are considered as lucrative markets for the incretin-based drugs due to the increased awareness about diabetes and the good management of the disease. The growth of the incretin-based drugs market is majorly influenced by the supportive policies that are implemented by the government. In many of the countries, the governments are providing support to the weaker sections of the society to have the access to the diabetes drugs so that they have access to quality healthcare.

Global Incretin-Based Drugs Market: Competitive Players

The key market players that are involved in the incretin-based drugs market include Boehringer Ingelheim GmbH., GlaxoSmithKline Plc., Merck & Co., Inc., Takeda Pharmaceutical Company Ltd., Sanofi S.A., AstraZeneca Plc., Eli Lilly and Company, Johnson & Johnson, and Novartis AG.

Global Incretin-Based Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Rheumatoid Arthritis Drugs Market by Drug Type (NSAID’s, Analgesics, DMARD’s, Glucocorticoids, Biologics, and Others) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Apr-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3999 | Report Format:

The report covers a forecast and an analysis of the rheumatoid arthritis drugs market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the rheuma...Read More

Pharmaceutical Vials Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3985 | Report Format:

Global Pharmaceutical Vials Market: Overview Pharmaceutical vials are a type of small containers that are used for the purpose of storing liquid medications. They are made up of plastic or glass and are mainly used for unit dose packaging of medications. Pharmaceutical vials also help patients i...Read More

Immuno Oncology Assays Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3963 | Report Format:

Global Immuno Oncology Assays Market: Overview Immuno Oncology Assays are used when testing immunotherapies as it is often critical to assess thefunctional cytotoxicity and infiltration capacity. In addition, Immunomodulators effects of these new drugs in combination with already approved ones n...Read More

Drug Integrated Polymer Fibers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3933 | Report Format:

Global Drug Integrated Polymer Fibers Market: Overview Drug integrated polymers fibers are generally made from biodegradable and biocompatible materials such as poly lactic acid and its derivatives such as PLLA, polydioxanone, polycaprolactone, polyglycolic acid, poly(lactic-co-glycolic acid), a...Read More

Gynecological Drugs Market by Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), by Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, Contraception (Birth Control), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Mar-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3926 | Report Format:

The report covers a forecast and an analysis of the gynecological drugs market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the gyneco...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.